Article Information
History
- April 11, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Abhishek B. Sharma1,12,
- Hélène Erasimus1,2,12,
- Lia Pinto1,2,
- Marie-Christine Caron3,4,
- Katrin Neumann1,
- Petr V. Nazarov5,
- Barbara Klink6,7,
- Sabrina Fritah8,
- Christel C. Herold-Mende9,
- Simone P. Niclou8,10,
- Patrick Calsou11,13,
- Jean-Yves Masson3,4,13,
- Sébastien Britton11,13 and
- Eric Van Dyck1,14,*
- 1DNA Repair and Chemoresistance Group, Department of Oncology, Luxembourg Institute of Health (LIH), Luxembourg, Luxembourg
- 2Faculty of Science, Technology and Communication, University of Luxembourg, Esch-sur-Alzette, Luxembourg
- 3CHU de Québec Research Center, Oncology Division, Québec City, Canada
- 4Department of Molecular Biology, Medical Biochemistry and Pathology, Laval University Cancer Research Center, Québec City, Canada
- 5Quantitative Biology Unit, Multiomics Data Science Group, LIH, Luxembourg, Luxembourg
- 6National Center of Genetics, Laboratoire National de Santé, Dudelange, Luxembourg
- 7Functional Tumour Genetics Group, Department of Oncology, LIH, Luxembourg
- 8NorLux Neuro-Oncology Laboratory, Department of Oncology, LIH, Luxembourg
- 9Department of Neurosurgery, University Clinic Heidelberg, Heidelberg, Germany
- 10Department of Biomedicine, University of Bergen, Norway
- 11Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France, Equipe Labellisée Ligue Nationale Contre le Cancer 2018
- ↵*Correspondance: Eric.vandyck{at}lih.lu